Oxidative Stress in Inflammatory Bowel Disease: From Redox Dysregulation to Translational Targeting
Antioxidants · 20.07.2026 · 15 (7) · 894
DOI: 10.3390/antiox15070894 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Antioxidants, online erschienen am 20.07.2026. Verfasst von Alexandra Laura Mederle und 6 weiteren Autor:innen. Beteiligte Einrichtung: Doctoral School Medicine-Pharmacy, "Victor Babes" University of Medicine and Pharmacy Timisoara, Eftimie Murgu Square No. 2, 300041 Timisoara, Romani…. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Oxidative stress has emerged as an important component of the complex pathophysiology of inflammatory bowel disease (IBD), where increasing evidence suggests an interaction between redox imbalance, immune activation, epithelial dysfunction, and chronic intestinal inflammation. This structured narrative review critically synthesizes current evidence regarding the biological basis of oxidative stress in IBD, with emphasis on cellular and molecular mechanisms, oxidative biomarkers, therapeutic modulation of redox pathways, and their translational relevance. Current evidence indicates that oxidative stress is associated with immune-cell activation, mitochondrial dysfunction, impairment of epithelial homeostasis, and dysregulation of redox-sensitive signaling pathways. Biomarkers including nitric oxide metabolites, malondialdehyde, myeloperoxidase, total antioxidant capacity, serum thiols, and antioxidant enzymes have demonstrated associations with inflammatory activity, while anti-inflammatory, antioxidant, and dietary interventions have been reported to modulate oxidative biomarkers in selected clinical studies. However, substantial methodological heterogeneity, variability in analytical techniques, and limited prospective validation currently restrict their routine clinical application. Moreover, many mechanistic pathways have been characterized predominantly in experimental models, highlighting the need to distinguish biological plausibility from evidence supporting clinical implementation. Overall, oxidative stress represents a promising area of investigation that may contribute to a better understanding of IBD biology and support future biomarker-guided and precision medicine approaches. Nevertheless, further standardized translational and longitudinal clinical studies are required before oxidative biomarkers and redox-targeted strategies can be integrated into routine patient care.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Doctoral School Medicine-Pharmacy, "Victor Babes" University of Medicine and Pharmacy Timisoara, Eftimie Murgu Square No. 2, 300041 Timisoara, Romania.
- Department of Microbiology, Discipline of Dermatology, "Victor Babes" University of Medicine and Pharmacy, Eftimie Murgu Square 2, 300041 Timisoara, Romania.
- Department of Functional Sciences, Discipline of Physiopathology, Faculty of Medicine, "Victor Babes" University of Medicine and Pharmacy, Eftimie Murgu Sq. No. 2, 300041 Timisoara, Romania.
- Centre for Translational Research and Systems Medicine, "Victor Babeș" University of Medicine and Pharmacy of Timișoara, 300041 Timisoara, Romania.
- Institute for Cardiovascular Diseases of Timisoara, Clinic for Cardiovascular Surgery, 300310 Timisoara, Romania.
- Department of Internal Medicine, Diabetes, Nutrition and Metabolic Diseases, "Victor Babeș" University of Medicine and Pharmacy, 300041 Timisoara, Romania.
ORCID-Profile: Ana Lascu, Andrei Raul Manzur, Alexandru Caraba, Raluca Elisabeta Staicu
Zitieren
APA
Mederle, A. L., Lascu, A., Manzur, A. R., Caraba, A., Staicu, R. E., Noveanu, L., & Aburel, O. M. (2026). Oxidative Stress in Inflammatory Bowel Disease: From Redox Dysregulation to Translational Targeting. Antioxidants, 15(7), 894. https://doi.org/10.3390/antiox15070894
Vancouver
Mederle AL, Lascu A, Manzur AR, Caraba A, Staicu RE, Noveanu L, et al. Oxidative Stress in Inflammatory Bowel Disease: From Redox Dysregulation to Translational Targeting. Antioxidants. 2026;15(7):894. doi:10.3390/antiox15070894
BibTeX
@article{Mederle2026,
author = {Mederle, Alexandra Laura and Lascu, Ana and Manzur, Andrei Raul and Caraba, Alexandru and Staicu, Raluca Elisabeta and Noveanu, Lavinia and Aburel, Oana Maria},
title = {Oxidative Stress in Inflammatory Bowel Disease: From Redox Dysregulation to Translational Targeting},
journal = {Antioxidants},
year = {2026},
volume = {15},
number = {7},
pages = {894},
doi = {10.3390/antiox15070894}
}
EUVIMED